What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Heartworm Disease in Dogs: Prevention and Diagnostic Advances

Introduction

Heartworm disease in dogs is a potentially fatal cardiopulmonary condition caused by the filarial nematode Dirofilaria immitis. The parasite is transmitted through the bite of an infected mosquito, with the third-stage larvae (L3) entering the host through the puncture wound. Over a period of approximately 6 to 7 months, these larvae molt through the fourth stage (L4) and finally into immature adult worms that reside in the pulmonary arteries and right ventricle [1, 2]. Adult worms can reach lengths of 15 to 30 cm and survive for 5 to 7 years within the canine host [3]. The disease is characterized by endothelial damage, pulmonary hypertension, right-sided heart failure, and in severe cases, caval syndrome [4].

The global distribution of D. immitis is expanding due to climate change, increased vector range, and movement of infected animals [5, 6]. This review provides a detailed examination of the biological mechanisms underlying prevention and the technological advances in diagnostic modalities. Emphasis is placed on the pharmacokinetics of macrocyclic lactones, the role of the obligate intracellular bacterium Wolbachia in pathogenesis, and the physical and chemical principles of antigen, microfilarial, and molecular detection assays.

Pathophysiology and Host-Parasite Interactions

Life Cycle and Tissue Migration

The life cycle of D. immitis begins when a mosquito ingests microfilariae (first-stage larvae, L1) during a blood meal from an infected dog. Within the mosquito vector, larvae develop through L2 and L3 stages over 10 to 14 days, depending on ambient temperature [7]. Infective L3 larvae are deposited onto the skin during subsequent feeding and actively penetrate the bite wound. Larvae migrate through subcutaneous tissues and muscle, molting to L4 within 1 to 12 days post-infection [8]. The final molt to immature adults occurs approximately 50 to 70 days post-infection, after which worms enter the venous circulation and travel to the pulmonary arteries [9].

Vascular Pathology

Adult worms induce a chronic inflammatory response characterized by myointimal proliferation, villous endarteritis, and thrombosis of the pulmonary arteries [10]. These changes increase pulmonary vascular resistance and lead to pulmonary hypertension. The mechanical obstruction caused by worm masses, combined with the release of vasoactive mediators, results in endothelial dysfunction [11]. In heavy infections, worms may occupy the right ventricle and vena cava, causing caval syndrome, a life-threatening condition marked by hemolysis, hemoglobinuria, and acute right heart failure [12].

The Role of Wolbachia

Wolbachia is an obligate intracellular alphaproteobacterium that infects the reproductive tissues and hypodermal cells of D. immitis [13]. The symbiont is essential for worm embryogenesis, larval development, and adult worm survival [14]. The release of Wolbachia surface protein (WSP) and other bacterial components during worm death triggers a potent host inflammatory response [15]. This response is characterized by activation of Toll-like receptors (TLR2 and TLR4), leading to the production of pro-inflammatory cytokines including tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) [16]. The inflammatory reaction contributes significantly to the pulmonary pathology observed in heartworm disease. Targeting Wolbachia with doxycycline has been shown to reduce worm viability and decrease the severity of post-adulticide thromboembolic complications [17, 18].

Prevention: Macrocyclic Lactones

Mechanism of Action

Macrocyclic lactones (MLs) are the cornerstone of heartworm prevention. This class includes ivermectin, milbemycin oxime, moxidectin, and selamectin. MLs potentiate glutamate-gated chloride channels in nematode neurons and pharyngeal muscle cells, leading to hyperpolarization, paralysis, and death of susceptible larval stages [19]. The drugs are effective against L3 and L4 larvae but have limited efficacy against adult worms [20]. The selective toxicity of MLs in nematodes versus mammals is due to the absence of glutamate-gated chloride channels in vertebrate nervous systems [21].

Pharmacokinetic Considerations

The prophylactic efficacy of MLs depends on maintaining therapeutic concentrations during the period of larval susceptibility. Ivermectin and milbemycin oxime are administered orally at monthly intervals, while moxidectin is available in both oral and sustained-release injectable formulations [22]. The sustained-release injectable formulation of moxidectin provides protection for up to 12 months by forming a subcutaneous depot that releases the drug slowly over time [23]. The pharmacokinetic profile of each ML determines the dosing interval and the margin of safety. Ivermectin has a wide safety margin in dogs, although certain breeds, particularly those with a mutation in the ABCB1 (MDR1) gene, are susceptible to neurotoxicity due to impaired blood-brain barrier efflux [24].

Compliance and Resistance

The primary cause of prevention failure is owner non-compliance, including missed doses, late administration, and failure to administer the drug year-round [25]. However, reports of suspected ML resistance in D. immitis have emerged from the Mississippi River Delta region of the United States [26]. Isolates from these areas have demonstrated reduced susceptibility to MLs in experimental infection models [27]. The mechanism of resistance is not fully understood but may involve alterations in drug target sites (glutamate-gated chloride channel subunits) or increased drug efflux via P-glycoprotein transporters [28]. The emergence of resistance underscores the need for routine diagnostic testing to detect breakthrough infections.

Diagnostic Advances

Microfilarial Detection

Microfilariae are the first-stage larvae released by adult female worms into the bloodstream. Detection of microfilariae confirms the presence of adult worms and provides information on the reproductive status of the worm population. Traditional methods include the modified Knott test and direct smear examination [29]. The modified Knott test involves centrifugation of blood mixed with formalin, followed by staining of the sediment with methylene blue or Giemsa stain. This method allows for morphological differentiation of D. immitis microfilariae from those of Acanthocheilonema reconditum, a non-pathogenic filarial nematode [30]. D. immitis microfilariae measure 290 to 330 micrometers in length with a tapered anterior end and a straight tail, while A. reconditum microfilariae are shorter (250 to 290 micrometers) with a curved tail and a buttonhook-shaped anterior end [31].

Filter-based techniques, such as the Nuclepore filter test, use a polycarbonate membrane with 5-micrometer pores to trap microfilariae from lysed blood [32]. These methods offer higher sensitivity than direct smears but are more labor-intensive. Automated impedance-based hematology analyzers can detect microfilariae as large particles during complete blood count analysis, although this method lacks specificity and requires confirmation [33].

Antigen Testing

Antigen testing detects the presence of adult female worm antigens, specifically a glycoprotein shed from the reproductive tract of gravid females [34]. Commercial enzyme-linked immunosorbent assays (ELISAs) and immunochromatographic lateral flow assays are widely used in veterinary practice. The principle of these assays involves capture of circulating antigen by immobilized antibodies, followed by detection with enzyme-conjugated or gold-conjugated secondary antibodies [35]. The sensitivity of antigen testing is high for infections with two or more adult female worms, but sensitivity decreases in infections with only one female worm or with immature worms [36].

Heat treatment of serum or plasma prior to antigen testing has been shown to improve sensitivity by dissociating antigen-antibody complexes that may cause false-negative results [37]. This technique is particularly useful in cases of occult infections, where circulating antigen is bound by host antibodies and is not detectable by standard assays [38]. The mechanism involves heating samples to 100 degrees Celsius for 10 minutes, which denatures immunoglobulins and releases bound antigen for detection [39].

Molecular Diagnostics

Polymerase chain reaction (PCR) assays targeting the mitochondrial cytochrome c oxidase subunit I (COI) gene or the 12S rRNA gene of D. immitis offer high sensitivity and specificity for detection of microfilarial DNA in blood samples [40]. Real-time PCR (qPCR) allows for quantification of parasite DNA, which correlates with microfilarial burden [41]. PCR is particularly useful for confirming the identity of microfilariae when morphological differentiation is ambiguous and for detecting low-level infections that may be missed by antigen testing [42].

Loop-mediated isothermal amplification (LAMP) assays have been developed for field-based detection of D. immitis DNA [43]. LAMP operates at a constant temperature (60 to 65 degrees Celsius) and does not require thermal cycling equipment, making it suitable for point-of-care use in resource-limited settings [44]. The assay amplifies target DNA with high specificity using four to six primers that recognize distinct regions of the target sequence [45].

Imaging

Thoracic radiography remains a valuable tool for assessing the severity of pulmonary pathology in heartworm-positive dogs. Characteristic findings include enlargement of the main pulmonary artery segment, tortuous and blunted peripheral pulmonary arteries, and interstitial to alveolar pulmonary infiltrates [46]. In chronic cases, right ventricular enlargement and caudal vena cava dilation may be observed [47].

Echocardiography can directly visualize adult worms in the pulmonary arteries and right heart chambers. Worms appear as parallel, hyperechoic linear structures within the vessel lumen [48]. Echocardiography is particularly useful for diagnosing caval syndrome and for monitoring worm burden during treatment [49].

Diagnostic Algorithm

The following Mermaid diagram illustrates a recommended diagnostic workflow for canine heartworm disease.

flowchart TD
    A[Canine patient presented for heartworm testing], > B{Perform antigen test and microfilarial test}
    B, > C[Antigen positive, microfilariae positive]
    B, > D[Antigen positive, microfilariae negative]
    B, > E[Antigen negative, microfilariae positive]
    B, > F[Antigen negative, microfilariae negative]
    C, > G[Confirm infection: adult worms and microfilariae present]
    D, > H[Occult infection: perform heat treatment and retest antigen]
    H, > I[Antigen positive after heat treatment]
    I, > J[Confirm adult worm infection]
    H, > K[Antigen negative after heat treatment]
    K, > L[Consider PCR or imaging for confirmation]
    E, > M[Perform PCR for species identification]
    M, > N[If D. immitis confirmed, consider low female worm burden or male-only infection]
    F, > O[No evidence of infection: continue prevention]
    G, > P[Initiate adulticide treatment with doxycycline and macrocyclic lactone]
    J, > P
    N, > P

Treatment and the Role of Wolbachia

Adulticide therapy involves administration of melarsomine dihydrochloride, an arsenical compound that kills adult worms [50]. The standard protocol includes an initial dose followed by a two-dose series 24 hours later, with strict exercise restriction to reduce the risk of thromboembolic complications [51]. Prior to adulticide therapy, administration of doxycycline for 4 weeks targets Wolbachia, reducing the inflammatory response associated with worm death [52]. The combination of doxycycline and a macrocyclic lactone has been shown to reduce microfilarial counts and decrease the severity of post-treatment complications [53].

Conclusion

Heartworm disease in dogs remains a significant clinical challenge despite the availability of effective preventive medications. Advances in diagnostic technology, including heat-treated antigen testing, molecular assays, and improved imaging techniques, have enhanced the ability to detect infections at earlier stages and with greater accuracy. The role of Wolbachia in pathogenesis has opened new avenues for therapeutic intervention, and ongoing surveillance for macrocyclic lactone resistance is essential for maintaining the efficacy of prevention programs. Continued research into the molecular mechanisms of host-parasite interactions and drug resistance will inform future strategies for control and management.

References

[1] McCall JW, Genchi C, Kramer LH, Guerrero J, Venco L. Heartworm disease in animals and humans. Adv Parasitol. 2008;66:193-285.

[2] Kotani T, Powers KG. Developmental stages of Dirofilaria immitis in the dog. Am J Vet Res. 1982;43(12):2199-2206.

[3] Venco L, Marchesotti F, Manzocchi S. Feline heartworm disease: a clinical review. J Feline Med Surg. 2015;17(7):585-593.

[4] Atkins C. Heartworm disease. In: Ettinger SJ, Feldman EC, editors. Textbook of Veterinary Internal Medicine. 7th ed. Saunders; 2010. p. 1353-1375.

[5] Genchi C, Kramer LH, Rivasi F. Dirofilarial infections in Europe. Vector Borne Zoonotic Dis. 2011;11(10):1307-1317.

[6] Simon F, Siles-Lucas M, Morchon R, Gonzalez-Miguel J, Mellado I, Carreton E, et al. Human and animal dirofilariasis: the emergence of a zoonotic mosaic. Clin Microbiol Rev. 2012;25(3):507-544.

[7] Ledesma N, Harrington L. Fine-scale temperature fluctuation and modulation of Dirofilaria immitis larval development in Aedes aegypti. Vet Parasitol. 2015;209(1-2):93-100.

[8] Lok JB, Walker ED, Scoles GA. Filarial worm infections. In: Mullen GR, Durden LA, editors. Medical and Veterinary Entomology. 3rd ed. Academic Press; 2019. p. 305-326.

[9] Abraham D. Biology of Dirofilaria immitis. In: Boreham PFL, Atwell RB, editors. Dirofilariasis. CRC Press; 1988. p. 29-46.

[10] Schaub RG, Rawlings CA, Keith JC. Platelet adhesion and myointimal proliferation in canine pulmonary arteries. Am J Pathol. 1981;104(1):13-22.

[11] Dillon AR, Warner AE, Molina RM, Brawner WR, Spence S. Pulmonary vascular remodeling in dogs with heartworm disease. Vet Pathol. 1995;32(5):505-512.

[12] Kitagawa H, Sasaki Y, Ishihara K, Kawakami M. Clinical and laboratory findings in dogs with caval syndrome. J Am Vet Med Assoc. 1986;188(9):1015-1019.

[13] Sironi M, Bandi C, Sacchi L, Di Sacco B, Damiani G, Genchi C. Molecular evidence for a close relative of the arthropod endosymbiont Wolbachia in a filarial worm. Mol Biochem Parasitol. 1995;74(2):223-227.

[14] Taylor MJ, Bandi C, Hoerauf A. Wolbachia bacterial endosymbionts of filarial nematodes. Adv Parasitol. 2005;60:245-284.

[15] Brattig NW, Bazzocchi C, Kirschning CJ, Reiling N, Buttner DW, Ceciliani F, et al. The major surface protein of Wolbachia endosymbionts in filarial nematodes elicits immune responses through TLR2 and TLR4. J Immunol. 2004;173(1):437-445.

[16] Turner JD, Langley RS, Johnston KL, Gentil K, Ford L, Wu B, et al. Wolbachia lipoprotein stimulates innate and adaptive immunity through Toll-like receptors. Infect Immun. 2009;77(10):4402-4412.

[17] Bandi C, McCall JW, Genchi C, Corona S, Venco L, Sacchi L. Effects of tetracycline on the filarial worm Brugia pahangi and Dirofilaria immitis and their bacterial endosymbionts Wolbachia. Int J Parasitol. 1999;29(2):357-364.

[18] Kramer L, Grandi G, Leoni M, Passeri B, McCall J, Genchi C, et al. Wolbachia and its influence on the pathology and immunology of Dirofilaria immitis infection. Vet Parasitol. 2008;158(3):191-195.

[19] Cully DF, Vassilatis DK, Liu KK, Paress PS, Van der Ploeg LH, Schaeffer JM, et al. Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature. 1994;371(6499):707-711.

[20] McCall JW. The safety-net story about macrocyclic lactone heartworm preventives: a review. Vet Parasitol. 2005;133(2-3):197-203.

[21] Wolstenholme AJ, Rogers AT. Glutamate-gated chloride channels and the mode of action of avermectin/milbemycin anthelmintics. Parasitology. 2005;131(Suppl):S85-S95.

[22] Bowman DD, Mannella C. Macrocyclic lactones and Dirofilaria immitis microfilariae. Top Companion Anim Med. 2011;26(3):160-164.

[23] McTier TL, Pullins A, Inskeep GA, Schenker R, McCall JW, Genchi C, et al. Prophylactic efficacy of a sustained-release injectable formulation of moxidectin against experimental heartworm infection in dogs. Vet Parasitol. 2017;243:19-24.

[24] Mealey KL, Bentjen SA, Gay JM, Cantor GH. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics. 2001;11(8):727-733.

[25] Drake J, Wiseman S, Smith V, Hackett T. Compliance with heartworm prevention in dogs: a retrospective analysis of veterinary medical records. J Am Vet Med Assoc. 2015;247(6):642-648.

[26] Pulaski CN, Malone JB, Bourguinat C, Prichard R, Geary T, Ward D, et al. Establishment of macrocyclic lactone resistant Dirofilaria immitis isolates in experimentally infected dogs. Parasit Vectors. 2014;7:494.

[27] Bourguinat C, Lee AC, Lizundia R, Blagburn BL, Liotta JL, Kraus MS, et al. Macrocyclic lactone resistance in Dirofilaria immitis: failure of heartworm preventives and investigation of genetic markers for resistance. Vet Parasitol. 2015;210(3-4):167-178.

[28] Prichard RK. Genetic variability and drug resistance in parasitic nematodes. Int J Parasitol. 2001;31(5-6):587-594.

[29] Courtney CH, Zeng QY. Comparison of heartworm antigen test kits and the Knott test for detection of Dirofilaria immitis infection in dogs. J Am Vet Med Assoc. 1991;199(1):81-83.

[30] Lindsey JR. Identification of canine microfilariae. J Am Vet Med Assoc. 1965;146:1106-1114.

[31] Newton WL, Wright WH. The occurrence of a filariid parasite in the subcutaneous tissues of dogs in the United States. J Parasitol. 1956;42(3):246-248.

[32] Wylie JP, Greene RT. Evaluation of a filter technique for detection of canine microfilariae. Vet Clin Pathol. 1986;15(2):23-25.

[33] Tvedten H, Moritz A. Detection of microfilariae in dogs using the ADVIA 2120 hematology analyzer. Vet Clin Pathol. 2005;34(4):377-380.

[34] Weil GJ, Malane MS, Powers KG, Blair LS. Monoclonal antibodies to parasite antigens found in the serum of Dirofilaria immitis-infected dogs. J Immunol. 1985;134(2):1185-1191.

[35] Courtney CH, Zeng QY, Tonelli Q. Sensitivity and specificity of a commercial heartworm antigen test. J Am Vet Med Assoc. 1990;196(12):1951-1953.

[36] Atkins CE. Comparison of results of three commercial heartworm antigen test kits. J Am Vet Med Assoc. 1993;203(7):1017-1020.

[37] Little SE, Munzing C, Heise SR, Allen KE, Starkey LA, Johnson EM, et al. Pre-treatment with heat facilitates detection of antigen of Dirofilaria immitis in canine samples. Vet Parasitol. 2014;203(1-2):250-252.

[38] Velasquez L, Blagburn BL, Duncan-Decocq R, Johnson EM, Allen KE, Meinkoth J, et al. Increased prevalence of Dirofilaria immitis antigen in canine samples after heat treatment. Vet Parasitol. 2014;206(1-2):67-70.

[39] DiGangi BA, Dworkin C, Stull JW, Yaglom HD, Galloway R, Blagburn BL, et al. Impact of heat treatment on Dirofilaria immitis antigen detection in shelter dogs. Parasit Vectors. 2017;10(Suppl 2):483.

[40] Rishniw M, Barr SC, Simpson KW, Frongillo MF, Franz M, Dominguez Alpizar JL. Discrimination between six species of canine microfilariae by a single polymerase chain reaction. Vet Parasitol. 2006;135(3-4):303-314.

[41] Laidoudi Y, Ringot D, Watier-Grillot S, Davoust B, Mediannikov O. A real-time PCR assay for detection and quantification of Dirofilaria immitis in canine blood samples. Parasit Vectors. 2020;13:50.

[42] Alho AM, Landum M, Ferreira C, Meireles J, Goncalves L, de Carvalho LM, et al. Prevalence and seasonal variations of canine dirofilariosis in Portugal. Vet Parasitol. 2014;206(1-2):99-105.

[43] Areekit S, Kanjanavas P, Khawsak P, Pakpitcharoen A, Potivejkul K, Chansiri K. Development of a rapid and sensitive loop-mediated isothermal amplification assay for detection of Dirofilaria immitis. Mol Cell Probes. 2009;23(5):221-226.

[44] Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000;28(12):E63.

[45] Mori Y, Notomi T. Loop-mediated isothermal amplification (LAMP): a rapid, accurate, and cost-effective diagnostic method for infectious diseases. J Infect Chemother. 2009;15(2):62-69.

[46] Thrall DE, Badertscher RR, McCall JW, Lewis RE. The radiographic features of canine heartworm disease. Vet Radiol. 1980;21(4):174-178.

[47] Losonsky JM, Thrall DE, Lewis RE. Thoracic radiographic abnormalities in dogs with heartworm disease. J Am Vet Med Assoc. 1983;182(3):267-271.

[48] Venco L, Genchi C, Vigevani Colosio P, Kramer L. Relative utility of echocardiography and radiography for the diagnosis of canine heartworm disease. Vet Radiol Ultrasound. 2003;44(5):529-534.

[49] Badertscher RR, Losonsky JM, Paul AJ, Kneller SK. Two-dimensional echocardiography for detection of heartworms in dogs. Vet Radiol. 1984;25(5):220-224.

[50] Keister DM, Dzimianski MT, McTier TL, McCall JW, Brown J, Brown SA, et al. Dose selection and confirmation of a new adulticide for Dirofilaria immitis in dogs. Vet Parasitol. 1992;42(3-4):257-268.

[51] Nelson CT, McCall JW, Rubin SB, Buzhardt LF, Doiron DW, Graham W, et al. 2014 guidelines for the diagnosis, prevention and management of heartworm (Dirofilaria immitis) infection in dogs. Vet Parasitol. 2014;206(1-2):1-11.

[52] Bazzocchi C, Mortarino M, Grandi G, Kramer LH, Genchi C, Bandi C, et al. Combined ivermectin and doxycycline treatment has microfilaricidal and adulticidal activity against Dirofilaria immitis in experimentally infected dogs. Int J Parasitol. 2008;38(12):1401-1410.

[53] Grandi G, Quintavalla C, Mavropoulou A, Genchi M, Gnudi G, Bertoni G, et al. A combination of doxycycline and ivermectin is adulticidal in dogs with naturally acquired heartworm disease (Dirofilaria immitis). Vet Parasitol. 2010;169(3-4):347-351.